IKT-001
IKT-001-201
Phase 3 small_molecule active
Quick answer
IKT-001 for Pulmonary Arterial Hypertension is a Phase 3 program (small_molecule) at Inhibikase Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Inhibikase Therapeutics
- Indication
- Pulmonary Arterial Hypertension
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active